전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,019 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleMinicirclePhase 1

Injectable Plasmid Klotho Gene Therapy (Injectable Plasmid Klotho Gene Therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
AntibodyLimited DatastaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#monoclonal-antibody#HepatocellularCarcinomaHCC+2
Trials 2Status Recruiting
CGTLimited DatastaleRenJi HospitalPhase 1

JWCAR201 (JWCAR201)

Diffuse Large B Cell Lymphoma · B-cell Tumors

#B-cellTumors#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleMerckPhase 1

pembrolizumab (Keytruda, Letetresgene autoleucel with pembrolizumab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#Merck
Trials 2Status Discontinued
CGTLimited DatastaleSeigo NishidaPhase 1

Liver NK cell inoculation (Liver NK cell inoculation)

Liver Cirrhosis; Hepatocellular Carcinoma · Liver Cirrhosis

#LiverCirrhosis#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 2Status Recruiting
AntibodyLimited DatastaleTakedaPhase 2

Mezagitamab (Mezagitamab)

Relapsed and/or Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#monoclonal-antibody#Relapsedand+2
Trials 2Status Active
AntibodyLimited DatastaleBeiGenePhase 3

Ociperlimab (Ociperlimab)

Advanced Hepatocellular Carcinoma · FRα

#FR#Antibody#Phase3#monoclonal-antibody#AdvancedHepatocellularCarcinoma+1
Trials 2Status Discontinued
AntibodyLimited DatastaleAbbViePhase 3

adalimumab (Humira, Open-label Adalimumab)

Axial Spondyloarthritis · Axial Spondyloarthritis

#AxialSpondyloarthritis#Antibody#Phase3#monoclonal-antibody#AbbVie
Trials 2Status Active
CGTLimited DatastaleOriCell Therapeutics Co., Ltd.Phase 2

OriCAR-017 (OriCAR-017)

Relapsed and/or Refractory Multiple Myeloma · Neoplasms, Plasma Cell

#NeoplasmsPlasmaCell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
ADCLimited DatastaleDaiichi SankyoPhase 2

Patritumab (Patritumab)

Head and Neck Neoplasms · Squamous Cell Carcinoma of the Head and

#SquamousCellCarcinomaoftheHeadan#ADC#Phase2#antibody-drug-conjugate#HeadandNeckNeoplasms+1
Trials 2Status Active
AntibodyLimited DatastaleEli LillyPhase 2

Penpulimab combined with cetuximab (Penpulimab combined with cetuximab)

Head and Neck Neoplasms; Recurrent Disease · Head and Neck Neoplasms

#HeadandNeckNeoplasms#Antibody#Phase2#monoclonal-antibody#RecurrentDisease+1
Trials 2Status Recruiting
ADCLimited DatastaleGenentech, Inc.Phase 2

Pinatuzumab Vedotin (Pinatuzumab Vedotin)

Follicular Lymphoma; Diffuse Large B-Cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#ADC#Phase2#antibody-drug-conjugate#DiffuseLargeB-CellLymphoma+1
Trials 2Status Active
CGTLimited DatastaleNektar TherapeuticsPhase 1

Polymer-conjugated IL-15 Receptor Agonist NKTR-255 (Polymer-conjugated IL-15 Receptor Agonist NKTR-255)

Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

SC-CAR.GPC3xIL15.21 CAR T cells (SC-CAR.GPC3xIL15.21 CAR T cells)

Solid Tumor (Excluding CNS); Hepatocellular Carcinoma · Solid Tumor (Excluding CNS)

#SolidTumorExcludingCNS#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleSeoul National University Hospi…Phase 2

SNUH-CD19-CAR-T (SNUH-CD19-CAR-T)

Very High Risk Acute Lymphoblastic Leukemia; CD19 CAR-T Therapy · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
AntibodyLimited DatastaleNovartis PharmaceuticalsPreclinical

Secikinumab (Secikinumab)

Axial Spondylarthritis (axSpA); Secukinumab · Psoriasis

#Psoriasis#Antibody#Preclinical#monoclonal-antibody#AxialSpondylarthritisaxSpA+2
Trials 2Status Active
CGTAAVLimited DatastaleNeurologix, Inc.Phase 1

Surgical infusion of AAV-GAD into the subthalamic nucleus (Surgical infusion of AAV-GAD into the subthalamic nucleus)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Active
CGTLimited DatastaleInge Marie SvanePhase 1

TIL infusion (TIL infusion)

Melanoma (Skin); Skin Cancer · Metastatic Ovarian Cancer

#MetastaticOvarianCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting

18 / 51 pages

← PreviousNext →